2020
DOI: 10.1371/journal.pcbi.1007749
|View full text |Cite
|
Sign up to set email alerts
|

Complementary computational and experimental evaluation of missense variants in the ROMK potassium channel

Abstract: The renal outer medullary potassium (ROMK) channel is essential for potassium transport in the kidney, and its dysfunction is associated with a salt-wasting disorder known as Bartter syndrome. Despite its physiological significance, we lack a mechanistic understanding of the molecular defects in ROMK underlying most Bartter syndrome-associated mutations. To this end, we employed a ROMK-dependent yeast growth assay and tested single amino acid variants selected by a series of computational tools representative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(14 citation statements)
references
References 51 publications
1
11
0
Order By: Relevance
“…The accuracy of this method was previously corroborated in silico on a dataset of ~20,000 labelled human variants, and when compared with alternative approaches using multiple accuracy metrics, Rhapsody’s performance at that time consistently ranked among the highest [ 30 , 40 ]. We further experimentally verified the predictive power of Rhapsody using a yeast growth assay that reports on ROMK plasma membrane residence and channel function (see Introduction ) [ 31 ]. Using the experimental data from the yeast screen, we also previously computed receiver operating characteristic (ROC) curves and found that Rhapsody had the highest accuracy compared to Polyphen-2 [ 41 ] and EVmutation [ 42 ] (Computed AUROC was 0.86 for Rhapsody, as opposed to 0.81 and 0.77 for Polyphen-2 and EVmutation).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The accuracy of this method was previously corroborated in silico on a dataset of ~20,000 labelled human variants, and when compared with alternative approaches using multiple accuracy metrics, Rhapsody’s performance at that time consistently ranked among the highest [ 30 , 40 ]. We further experimentally verified the predictive power of Rhapsody using a yeast growth assay that reports on ROMK plasma membrane residence and channel function (see Introduction ) [ 31 ]. Using the experimental data from the yeast screen, we also previously computed receiver operating characteristic (ROC) curves and found that Rhapsody had the highest accuracy compared to Polyphen-2 [ 41 ] and EVmutation [ 42 ] (Computed AUROC was 0.86 for Rhapsody, as opposed to 0.81 and 0.77 for Polyphen-2 and EVmutation).…”
Section: Resultsmentioning
confidence: 99%
“…Using the experimental data from the yeast screen, we also previously computed receiver operating characteristic (ROC) curves and found that Rhapsody had the highest accuracy compared to Polyphen-2 [ 41 ] and EVmutation [ 42 ] (Computed AUROC was 0.86 for Rhapsody, as opposed to 0.81 and 0.77 for Polyphen-2 and EVmutation). Importantly, Rhapsody predicted the severity of known disease-linked ROMK mutations with >90% accuracy [ 31 ].…”
Section: Resultsmentioning
confidence: 99%
“…For example, twelve tools were systematically benchmarked for evaluating the pathogenic impact of the variants of a voltage-gated sodium channel, hNav1.5 [226] , and determined more than 70 potential pathogenic variants in both TM and extracellular regions. In another study, several tools (e.g., Rhapsody and EVmutation) were employed to determine deleterious mutations in the renal outer medullary potassium channel [227] . Crucially, training these tools with high prediction capacity depends heavily upon the availability of high-confidence experimental data.…”
Section: Mutation Effect Predictionmentioning
confidence: 99%
“…However, only rarely are KCNJ2 pathogenic variants associated with trafficking defects ( 80 ) and alternative DMS approaches for measuring Kir2.1 might be better suited. One possible DMS approach is to adapt yeast-based functional assays that demonstrate normal and LoF variants based on growth patterns, which have been reported for ATS-associated Kir2.1 ( 73 ) and Barter Syndrome-associated Kir1.1 (a Kir2.1 paralog that is not arrhythmia related) ( 81 ). Regardless, development of a potassium channel DMS is needed for this important arrhythmogenic and underrepresented DMS data group.…”
Section: K + Channelsmentioning
confidence: 99%